These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11788049)

  • 1. beta-Amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based ProteinChip technology.
    Vehmas AK; Borchelt DR; Price DL; McCarthy D; Wills-Karp M; Peper MJ; Rudow G; Luyinbazi J; Siew LT; Troncoso JC
    DNA Cell Biol; 2001 Nov; 20(11):713-21. PubMed ID: 11788049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration and specificity of humoral immune responses in mice vaccinated with the Alzheimer's disease-associated beta-amyloid 1-42 peptide.
    Dickey CA; Morgan DG; Kudchodkar S; Weiner DB; Bai Y; Cao C; Gordon MN; Ugen KE
    DNA Cell Biol; 2001 Nov; 20(11):723-9. PubMed ID: 11788050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory.
    Arendash GW; Gordon MN; Diamond DM; Austin LA; Hatcher JM; Jantzen P; DiCarlo G; Wilcock D; Morgan D
    DNA Cell Biol; 2001 Nov; 20(11):737-44. PubMed ID: 11788052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's disease.
    Yang W; Chauhan A; Mehta S; Mehta P; Gu F; Chauhan V
    Life Sci; 2014 Mar; 99(1-2):31-6. PubMed ID: 24486299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active immunization of mice with an Abeta-Hsp70 vaccine.
    Koller MF; Mohajeri MH; Huber M; Wollmer MA; Roth Z'graggen BV; Sandmeier E; Moritz E; Tracy J; Nitsch RM; Christen P
    Neurodegener Dis; 2004; 1(1):20-8. PubMed ID: 16908970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
    Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.
    Schenk D; Barbour R; Dunn W; Gordon G; Grajeda H; Guido T; Hu K; Huang J; Johnson-Wood K; Khan K; Kholodenko D; Lee M; Liao Z; Lieberburg I; Motter R; Mutter L; Soriano F; Shopp G; Vasquez N; Vandevert C; Walker S; Wogulis M; Yednock T; Games D; Seubert P
    Nature; 1999 Jul; 400(6740):173-7. PubMed ID: 10408445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
    Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice.
    Santuccione AC; Merlini M; Shetty A; Tackenberg C; Bali J; Ferretti MT; McAfoose J; Kulic L; Bernreuther C; Welt T; Grimm J; Glatzel M; Rajendran L; Hock C; Nitsch RM
    Mol Psychiatry; 2013 Mar; 18(3):358-68. PubMed ID: 22688190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet.
    Lemere CA; Beierschmitt A; Iglesias M; Spooner ET; Bloom JK; Leverone JF; Zheng JB; Seabrook TJ; Louard D; Li D; Selkoe DJ; Palmour RM; Ervin FR
    Am J Pathol; 2004 Jul; 165(1):283-97. PubMed ID: 15215183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal inoculation with an adenovirus vaccine encoding ten repeats of Aβ3-10 reduces AD-like pathology and cognitive impairment in Tg-APPswe/PSEN1dE9 mice.
    Li Y; Ma Y; Zong LX; Xing XN; Guo R; Jiang TZ; Sha S; Liu L; Cao YP
    J Neuroimmunol; 2012 Aug; 249(1-2):16-26. PubMed ID: 22626444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered APP processing in PDAPP (Val717 --> Phe) transgenic mice yields extended-length Abeta peptides.
    Esh C; Patton L; Kalback W; Kokjohn TA; Lopez J; Brune D; Newell AJ; Beach T; Schenk D; Games D; Paul S; Bales K; Ghetti B; Castaño EM; Roher AE
    Biochemistry; 2005 Oct; 44(42):13807-19. PubMed ID: 16229470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice.
    Chua LM; Lim ML; Chong PR; Hu ZP; Cheung NS; Wong BS
    J Alzheimers Dis; 2012; 29(4):783-91. PubMed ID: 22337827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice.
    Li Q; Cao C; Chackerian B; Schiller J; Gordon M; Ugen KE; Morgan D
    BMC Neurosci; 2004 Jun; 5():21. PubMed ID: 15186505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modified preparation (LMK03) of the oriental medicine Jangwonhwan reduces Abeta(1-42) level in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.
    Seo JS; Jung EY; Kim JH; Lyu YS; Han PL; Kang HW
    J Ethnopharmacol; 2010 Aug; 130(3):578-85. PubMed ID: 20669372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
    Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
    J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice.
    Mably AJ; Liu W; Mc Donald JM; Dodart JC; Bard F; Lemere CA; O'Nuallain B; Walsh DM
    Neurobiol Dis; 2015 Oct; 82():372-384. PubMed ID: 26215784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving memory and decreasing cognitive impairment in Tg-APPswe/PSEN1dE9 mice with Aβ3-10 repeat fragment plasmid by reducing Aβ deposition and inflammatory response.
    Ma Y; Li Y; Zong LX; Xing XN; Zhang WG; Cao YP
    Brain Res; 2011 Jul; 1400():112-24. PubMed ID: 21658683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunization with recombinant HBcAg and β-amyloid peptide fusion protein promotes clearance of intrahippocampally injected β-amyloid peptide in rats].
    Feng GF; Hu HT; Jin H; Wang WX; Qian YH
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1236-9. PubMed ID: 21764704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.